Divi’s Laboratories has reported results for first quarter ended June 30, 2017.
The company has reported 41.51% fall in its net profit at Rs 176.54 crore for the quarter under review as compared to Rs 301.81 crore for the same quarter in the previous year. Total revenue from operations of the company decreased by 17.67% at Rs 850.88 crore for Q1FY18 as compared Rs 1033.50 crore for the corresponding quarter previous year.
Divi’s Laboratories focussed on developing new processes for the production of Active Pharma Ingredients (APIs) & Intermediates. The company in a matter of short time expanded its breadth of operations to provide complete turnkey solutions to the domestic Indian pharmaceutical industry.
Company Name | CMP |
---|---|
Sun Pharma Inds. | 1532.85 |
Dr. Reddys Lab | 5812.50 |
Cipla | 1403.90 |
Zydus Lifesciences | 1104.45 |
Lupin | 1661.90 |
View more.. |